Paper403149
Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man.
Aellig WH and 1 other. Int J Clin Pharmacol Biopharm, 1977. Cited by 116 papers, by iCite.
Cite this record
ConductScience Library. Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration man. Papers, record 403149. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/403149
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ergot Alkaloids | Major topic |
| Administration, Oral | |
| Adult | |
| Aged | |
| Ergoloid Mesylates | |
| Half-Life | |
| Humans | |
| Injections, Intravenous | |
| Kinetics | |
| Middle Aged | |
| Time Factors |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42016129 | Scientific Opinion on Ergot alkaloids in food and feed. | EFSA J | 2012 | https://conductscience.org/library/papers/42016129 | PubMed |
| 41432819 | Human biomonitoring of mycotoxins: key challenges and future directions. | Mycotoxin Res | 2025 | https://conductscience.org/library/papers/41432819 | PubMed |
| 38264299 | Risks for animal health related to the presence of ergot alkaloids in feed. | EFSA J | 2024 | https://conductscience.org/library/papers/38264299 | PubMed |
| 16409109 | Ergovaline movement across Caco-2 cells. | In Vitro Cell Dev Biol Anim | 2005 | https://conductscience.org/library/papers/16409109 | PubMed |
| 8884536 | Nasal spray vs oral administration of bromocriptine: pharmacology and effect on serum prolactin in puerperal women. | J Endocrinol Invest | 1996 | https://conductscience.org/library/papers/8884536 | PubMed |
| 8695044 | Differential regional and kinetics effects of piribedil and bromocriptine on dopamine metabolites: a brain microdialysis study in freely moving rats. | J Neural Transm Gen Sect | 1995 | https://conductscience.org/library/papers/8695044 | PubMed |
| 8057111 | The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa. | J Neurol Neurosurg Psychiatry | 1994 | https://conductscience.org/library/papers/8057111 | PubMed |
| 7427244 | Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension. | Br Med J | 1980 | https://conductscience.org/library/papers/7427244 | PubMed |
| 7308241 | Comparative blood level of dihydroergotoxine (DHET) after administration of two oral forms (solution & tablet): a preliminary study. | Eur J Drug Metab Pharmacokinet | 1981 | https://conductscience.org/library/papers/7308241 | PubMed |
| 7173294 | Kinetics of ergotamine after intravenous and intramuscular administration to migraine sufferers. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7173294 | PubMed |
| 7093108 | Bioavailability of dihydroergotamine in man. | Br J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7093108 | PubMed |
| 7088766 | Ergotamine absorption and toxicity. | Postgrad Med J | 1982 | https://conductscience.org/library/papers/7088766 | PubMed |
| 6861794 | Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism. | Eur J Drug Metab Pharmacokinet | 1983 | https://conductscience.org/library/papers/6861794 | PubMed |
| 6798600 | Binding of antiparkinsonian ergot derivatives to the dopamine receptor. | Psychopharmacology (Berl) | 1981 | https://conductscience.org/library/papers/6798600 | PubMed |
| 6786914 | Effects of dihydroergocriptine on mouse and rat resistance to acute anoxia: influence of repetition of treatment. | Experientia | 1981 | https://conductscience.org/library/papers/6786914 | PubMed |
| 6714287 | Steady state bioavailability of a new oral formulation of Hydergine in geriatric patients. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6714287 | PubMed |
| 6714270 | Interspecies similarities in the disposition of 3H-dihydroergotamine following subcutaneous administration in man and rabbits. | Eur J Drug Metab Pharmacokinet | 1984 | https://conductscience.org/library/papers/6714270 | PubMed |
| 6547094 | Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6547094 | PubMed |
| 6532807 | The pharmacokinetics and biotransformation of 14C-lisuride hydrogen maleate in rhesus monkey and in man. | Eur J Drug Metab Pharmacokinet | 1984 | https://conductscience.org/library/papers/6532807 | PubMed |
| 6489409 | Pharmacological actions of the main metabolites of dihydroergotamine. | Eur J Clin Pharmacol | 1984 | https://conductscience.org/library/papers/6489409 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/403149
GET https://conductscience.org/api/papers/v1/403149/cited_by?page=2